器械之家医疗器械媒体报道先锋分享专业医疗器械知识关注来源:Medtech Dive 医潜医疗科技巨头美敦力(NYSE:MDT)近期宣布,其最新一代自动胰岛素输送(AID)系统MiniMed 780G已获得CE标志认证,适应症范围扩展至2型糖尿病患者、2岁及以上1型糖尿病儿童及妊娠期糖尿病患者。此次认证标志着该设备在欧洲市场的应用人群显著扩大,同时为公司计划拆分成立的独立糖尿病业务公司MiniMed...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.